Mesoblast (MEOBF, $1.05) was a top weekly loser, falling to $1.05 per share. Of the 847 stocks analyzed in the Biotechnology Industry throughout the week of November 11/14/2024 - 11/21/2024, 2024, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.